{"id":365452,"date":"2025-09-01T06:21:42","date_gmt":"2025-09-01T06:21:42","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-evolent-health\/"},"modified":"2025-09-01T06:21:42","modified_gmt":"2025-09-01T06:21:42","slug":"how-to-buy-evolent-health","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/","title":{"rendered":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334063,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-365452","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Evolent Health (EVH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Evolent Health (EVH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Evolent Health, karma\u015f\u0131k t\u0131bbi durumlar i\u00e7in yapay zeka destekli \u00e7\u00f6z\u00fcmleriyle de\u011fer odakl\u0131 bak\u0131m\u0131n gelece\u011fini temsil ediyor. Bu \u015firket, teknoloji ve sa\u011fl\u0131k sekt\u00f6rlerinin kesi\u015fim noktas\u0131nda yer al\u0131yor\u2014her iki sekt\u00f6r de b\u00fcy\u00fck b\u00fcy\u00fcme potansiyeline sahip. EVH'nin neden bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini ve bunu tam olarak nas\u0131l ger\u00e7ekle\u015ftirece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Sa\u011fl\u0131k inovasyonuna yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Evolent Health, karma\u015f\u0131k t\u0131bbi durumlar i\u00e7in yapay zeka destekli \u00e7\u00f6z\u00fcmleriyle de\u011fer odakl\u0131 bak\u0131m\u0131n gelece\u011fini temsil ediyor. Bu \u015firket, teknoloji ve sa\u011fl\u0131k sekt\u00f6rlerinin kesi\u015fim noktas\u0131nda yer al\u0131yor\u2014her iki sekt\u00f6r de b\u00fcy\u00fck b\u00fcy\u00fcme potansiyeline sahip. EVH'nin neden bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini ve bunu tam olarak nas\u0131l ger\u00e7ekle\u015ftirece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel EVH Hisse Durumu ve Kritik Tarihler<\/h2> <p>1 Eyl\u00fcl 2025 itibar\u0131yla, Evolent Health (EVH) hisseleri <strong>9,64 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat, analistlerin potansiyel y\u00fckseli\u015f konusunda heyecanlanmas\u0131na neden oluyor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong>, bu hisseyi dramatik \u015fekilde hareket ettirebilecek bir sonraki kritik tarih.<\/p> <p>Evolent, 6 Kas\u0131m'da piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, tarih bize \u00f6nemli fiyat hareketleri g\u00f6rebilece\u011fimizi g\u00f6steriyor. \u015eirketin 7 A\u011fustos 2025'teki son kazan\u00e7 raporu, beklenen 0,08 $'a kar\u015f\u0131l\u0131k -0,10 $ EPS a\u00e7\u0131\u011f\u0131 ile kar\u0131\u015f\u0131k sonu\u00e7lar g\u00f6sterdi, ancak piyasa tepkisi, daha geni\u015f stratejik ilerlemeler g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u015fa\u015f\u0131rt\u0131c\u0131 derecede pozitif oldu.<\/p> <p><strong>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/strong><\/p> <ul> <li>7 A\u011fustos 2025: Kazan\u00e7 sonras\u0131 haftada hisse %7,97 de\u011fer kazand\u0131, a\u00e7\u0131\u011fa ra\u011fmen<\/li> <li>\u00d6nceki \u00e7eyrekler, kazan\u00e7 tarihleri civar\u0131nda ortalama %5-8 hareketler g\u00f6steriyor<\/li> <li>Sa\u011fl\u0131k teknolojisi hisseleri genellikle kazan\u00e7 sezonunda artan volatilite ya\u015far<\/li> <\/ul> <p>Bu desen, k\u0131sa vadeli sonu\u00e7lar\u0131n \u00f6nemli oldu\u011funu ancak yat\u0131r\u0131mc\u0131lar\u0131n giderek daha \u00e7ok Evolent'in uzun vadeli yapay zeka ve otomasyon stratejisine odakland\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>  [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: M\u00fccadeleden F\u0131rsata<\/h2> <p>Evolent Health son alt\u0131 ayda ini\u015f \u00e7\u0131k\u0131\u015flar ya\u015fad\u0131, ancak son geli\u015fmeler bir d\u00f6n\u00fcm noktas\u0131n\u0131 i\u015faret ediyor:<\/p> <p><strong>Mart 2025:<\/strong> 11,25-12,27 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<br\/> <strong>May\u0131s 2025:<\/strong> Daha geni\u015f piyasa belirsizli\u011fi i\u00e7inde yakla\u015f\u0131k 10,50 $ seviyesine d\u00fc\u015ft\u00fc<br\/> <strong>Temmuz 2025:<\/strong> G\u00fc\u00e7l\u00fc destekle 9,50 $ civar\u0131nda dip olu\u015fumu<br\/> <strong>A\u011fustos 2025:<\/strong> Yukar\u0131 y\u00f6nl\u00fc momentumla mevcut 9,64 $ seviyesine toparland\u0131<\/p> <p>Hisse, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 7,06 $'dan \u00f6nemli bir toparlanma g\u00f6stererek <strong>%21'lik bir iyile\u015fme<\/strong> sergiledi. \u00d6zellikle ilgi \u00e7ekici olan, i\u015flem hacmi desenidir\u2014son i\u015flem seanslar\u0131nda artan kurumsal ilgi g\u00f6zlemleniyor, bu da ak\u0131ll\u0131 paran\u0131n bu seviyelerde birikti\u011fini g\u00f6steriyor.<\/p> <p>Teknik g\u00f6stergeler pozitif sinyaller vermeye ba\u015flad\u0131; hisse \u00f6nemli hareketli ortalamalar\u0131n \u00fczerinde i\u015flem g\u00f6r\u00fcyor ve genel sa\u011fl\u0131k sekt\u00f6r\u00fcyle kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda g\u00f6receli g\u00fcc\u00fcn\u00fc art\u0131r\u0131yor.<\/p>  <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, bekleyebilecekleriniz \u015funlar:<\/p> <p><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> 14-16 $ (mevcut seviyelerden %45-65 y\u00fckseli\u015f)<br\/> Analistler \"G\u00fc\u00e7l\u00fc Al\" derecesini koruyor ve ortalama fiyat hedefi 16,93 $ (<a href=\"https:\/\/stockanalysis.com\/stocks\/evh\/forecast\/\">Stock Analysis<\/a>). Son d\u00f6n\u00fc\u015ft\u00fcr\u00fclebilir tahvil ihrac\u0131 ve yapay zeka platformu geni\u015flemesi g\u00fc\u00e7l\u00fc kataliz\u00f6rler sa\u011fl\u0131yor.<\/p> <p><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 18-22 $<br\/> Auth Intelligence platformu ivme kazand\u0131k\u00e7a ve yeni ortakl\u0131klar olgunla\u015ft\u0131k\u00e7a, gelir b\u00fcy\u00fcmesi h\u0131zlanmal\u0131 ve otomasyon avantajlar\u0131yla marjlar geni\u015flemeli.<\/p> <p><strong>2028 Projeksiyonu:<\/strong> 28-35 $<br\/> 2028 y\u0131l\u0131na kadar, Evolent'in yapay zeka destekli \u00e7\u00f6z\u00fcmleri, 150 milyar dolarl\u0131k uzman bak\u0131m toplam adreslenebilir pazar\u0131nda \u00f6nemli pazar pay\u0131 yakalayabilir ve de\u011ferlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rabilir.<\/p> <p><strong>2030 Vizyonu:<\/strong> 40-50+ $<br\/> Uzun vadeli analistler, Evolent'in 2030'da 40,52 $ seviyesine ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor (<a href=\"https:\/\/stockscan.io\/stocks\/EVH\/forecast\/\">StockScan<\/a>), bu da sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme anlam\u0131na geliyor.<\/p> <p><strong>Karar: G\u00dc\u00c7L\u00dc AL<\/strong> - Mevcut seviyelerde risk-getiri oran\u0131 uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in olduk\u00e7a elveri\u015fli g\u00f6r\u00fcn\u00fcyor.<\/p>  <h2>\u26a0\ufe0f Riskleri Anlamak: Neler Yanl\u0131\u015f Gidebilir<\/h2> <p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve EVH de istisna de\u011fil. \u0130\u015fte deneyimli yat\u0131r\u0131mc\u0131lar\u0131n geceleri uykusunu ka\u00e7\u0131ranlar:<\/p> <ul> <li><strong>Reg\u00fclasyon Riski:<\/strong> Sa\u011fl\u0131k sekt\u00f6r\u00fc s\u0131k\u0131 d\u00fczenlemelere tabidir ve politika de\u011fi\u015fiklikleri Evolent'in i\u015f modelini etkileyebilir. \u015eirket, farkl\u0131 uyum gereksinimlerine sahip bir\u00e7ok eyalette faaliyet g\u00f6steriyor.<\/li> <li><strong>Uygulama Riski:<\/strong> Yapay zeka stratejisi umut verici g\u00f6r\u00fcnse de, ba\u015far\u0131l\u0131 uygulama garantili de\u011fil. Sa\u011fl\u0131k teknolojisi alan\u0131, iyi finanse edilmi\u015f rakiplerle dolu.<\/li> <li><strong>Mali Risk:<\/strong> 647,5 milyon $ uzun vadeli bor\u00e7 ve nakit rezervlerinin %50 azalarak 151 milyon $'a d\u00fc\u015fmesi (<a href=\"https:\/\/www.ainvest.com\/news\/evolent-health-q2-2025-earnings-strategic-turnaround-sustainable-recovery-temporary-bounce-2508\/\">AInvest<\/a>) nedeniyle \u015firketin bilan\u00e7osunu dikkatle y\u00f6netmesi gerekiyor.<\/li> <li><strong>Piyasa Riski:<\/strong> 1,13 milyar $ piyasa de\u011feri ile EVH, k\u00f6kl\u00fc sa\u011fl\u0131k devlerine k\u0131yasla daha y\u00fcksek volatiliteye sahip k\u00fc\u00e7\u00fck sermayeli bir hisse senedidir.<\/li> <\/ul>  <h2>\ud83d\ude80 Pozitif Sinyaller: Bu 2025 Ticaretinizin En \u0130yisi Olabilir<\/h2> <p>Risklere ra\u011fmen, birka\u00e7 g\u00fc\u00e7l\u00fc kataliz\u00f6r EVH'nin ola\u011fan\u00fcst\u00fc getiri sa\u011flayabilece\u011fini g\u00f6steriyor:<\/p> <ul> <li><strong>Yapay Zeka Devrimi:<\/strong> Auth Intelligence platformunun idari maliyetleri %20-30 oran\u0131nda azaltmas\u0131 bekleniyor (<a href=\"https:\/\/www.ainvest.com\/news\/evolent-health-strategic-position-evolving-managed-care-landscape-2508\/\">AInvest<\/a>), bu da b\u00fcy\u00fck verimlilik art\u0131\u015flar\u0131 yaratacak.<\/li> <li><strong>B\u00fcy\u00fcyen \u0130\u015f Hatt\u0131:<\/strong> CEO Seth Blackley, \"yeni i\u015f i\u00e7in h\u0131zla ivmelenen bir i\u015f hatt\u0131\" oldu\u011funu ve 2026'da b\u00fcy\u00fcme oranlar\u0131n\u0131n tarihsel seviyelerin \u00fczerine \u00e7\u0131kmas\u0131n\u0131n beklendi\u011fini vurgulad\u0131.<\/li> <li><strong>Stratejik Finansman:<\/strong> Son 145 milyon $ tutar\u0131ndaki d\u00f6n\u00fc\u015ft\u00fcr\u00fclebilir tahvil ihrac\u0131 (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/evolent-health-inc-announces-pricing-of-oversubscribed-and-upsized-145-0-million-of-convertible-senior-notes-due-2031-to-repurchase-existing-notes-and-class-a-common-stock-302533122.html\">PR Newswire<\/a>) a\u015f\u0131r\u0131 talep g\u00f6rd\u00fc ve g\u00fc\u00e7l\u00fc kurumsal g\u00fcveni g\u00f6sterdi.<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131:<\/strong> De\u011fer odakl\u0131 bak\u0131m standart haline geliyor ve Evolent bu 150 milyar dolarl\u0131k pazar de\u011fi\u015fiminden faydalanmak i\u00e7in m\u00fckemmel konumda.<\/li> <\/ul>  <h2>\ud83d\udca1 Ak\u0131ll\u0131 Yat\u0131r\u0131mc\u0131 Stratejisi: Bug\u00fcn Ne Yapmal\u0131<\/h2> <p>EVH'ye yeni ba\u015flayanlar i\u00e7in eylem plan\u0131n\u0131z \u015f\u00f6yle:<\/p> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, sat\u0131n almalar\u0131n\u0131z\u0131 birka\u00e7 haftaya yayarak yap\u0131n<\/li> <li><strong>6 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7lar ge\u00e7ici bir d\u00fc\u015f\u00fc\u015f yarat\u0131rsa sat\u0131n almaya haz\u0131r olun<\/li> <li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 2-3 y\u0131ll\u0131k bir hikaye, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li> <\/ol> <p>Mizahi deneyimli tavsiye: \"EVH ticareti, t\u0131bbi test sonu\u00e7lar\u0131n\u0131 beklemek gibidir\u2014beklemek ac\u0131 verici ama te\u015fhis portf\u00f6y\u00fcn\u00fcz i\u00e7in hayat de\u011fi\u015ftirebilir!\"<\/p>  <h2>\u2705 Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m S\u00fcre\u00e7<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NYSE eri\u015fimi ve rekabet\u00e7i \u00fccretler sunan bir platform se\u00e7in<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Gerekli belgeleri sa\u011flay\u0131n\u2014bu genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Fon Yat\u0131r\u0131n<\/td><td>Tercih etti\u011finiz y\u00f6ntemle para transferi yap\u0131n (banka transferi vb.)<\/td><\/tr> <tr><td>4<\/td><td>\"EVH\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirket ad\u0131ndan ziyade sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>G\u00fcncel Fiyat\u0131 \u0130nceleyin<\/td><td>9,64 $'\u0131n platformunuzun fiyat teklifiyle uyumlu oldu\u011fundan emin olun<\/td><\/tr> <tr><td>6<\/td><td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in \"limit emir\" kullan\u0131n<\/td><\/tr> <tr><td>7<\/td><td>Hisse Adedini Belirleyin<\/td><td>Risk y\u00f6netimi plan\u0131n\u0131za uygun ka\u00e7 hisse alaca\u011f\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>8<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>\u0130\u015flemi ger\u00e7ekle\u015ftirmeden \u00f6nce t\u00fcm detaylar\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>9<\/td><td>Pozisyonunuzu Takip Edin<\/td><td>Hedef seviyeleriniz i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>10<\/td><td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td><td>K\u00e2r almay\u0131 veya zarar\u0131 durdurmay\u0131 \u00f6nceden kararla\u015ft\u0131r\u0131n<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83c\udf1f Pocket Option, EVH Yat\u0131r\u0131m\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor<\/h2> <p>Evolent Health gibi umut vadeden hisselerde pozisyon olu\u015fturmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, s\u00fcreci basitle\u015ftiren birka\u00e7 avantaj sunuyor:<\/p> <ul> <li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> - \u00d6\u011frenmek i\u00e7in rahat bir miktarla ba\u015flayabilirsiniz<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong> - Genellikle sadece bir belge ile dakikalar i\u00e7inde tamamlan\u0131r<\/li> <li><strong>\u00c7e\u015fitli Fonlama Se\u00e7enekleri<\/strong> - Y\u00fczlerce para yat\u0131rma ve \u00e7ekme y\u00f6ntemi mevcut<\/li> <li><strong>Par\u00e7al\u0131 Hisseler<\/strong> - Daha k\u00fc\u00e7\u00fck miktarlarla bile pozisyonunuzu kademeli olarak olu\u015fturabilirsiniz<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, teknik karma\u015f\u0131kl\u0131klardan ziyade yat\u0131r\u0131m kararlar\u0131na odaklanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>  <h2>\ud83c\udfe5 2025'te Evolent Health: Sa\u011fl\u0131k Hizmetlerinde D\u00f6n\u00fc\u015f\u00fcm<\/h2> <p>Evolent Health, kanser, kardiyovask\u00fcler hastal\u0131klar ve kas-iskelet sistemi bozukluklar\u0131 gibi karma\u015f\u0131k durumlar i\u00e7in de\u011fer odakl\u0131 bak\u0131m \u00e7\u00f6z\u00fcmlerinde \u00f6nc\u00fc konumdad\u0131r. \u015eirket, \u00fclke genelinde sa\u011fl\u0131k planlar\u0131 ve sa\u011flay\u0131c\u0131larla ortakl\u0131klar arac\u0131l\u0131\u011f\u0131yla yakla\u015f\u0131k 41,4 milyon \u00fcyeye hizmet vermektedir.<\/p> <p>Evolent'i 2025'te \u00f6zellikle heyecan verici k\u0131lan, yapay zeka destekli \u00e7\u00f6z\u00fcmlere y\u00f6nelik agresif ilerleyi\u015fidir. Auth Intelligence platformu, idari maliyetleri azalt\u0131rken hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirmede bir at\u0131l\u0131m\u0131 temsil ediyor. 2025'in 2. \u00e7eyre\u011finde d\u00f6rt yeni ortakl\u0131k sa\u011flanm\u0131\u015f ve h\u0131zla geni\u015fleyen bir i\u015f hatt\u0131 ile \u015firket \u00f6nemli b\u00fcy\u00fcme i\u00e7in konumlanm\u0131\u015ft\u0131r.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Evolent'in yapay zeka platformu, insan y\u00f6neticilerin saatlerce s\u00fcren t\u0131bbi onay taleplerini sadece saniyeler i\u00e7inde, %95'in \u00fczerinde do\u011frulukla i\u015fleyebiliyor. Bu sadece kademeli bir iyile\u015fme de\u011fil; sa\u011fl\u0131k y\u00f6netiminin dijital \u00e7a\u011f i\u00e7in yeniden icad\u0131d\u0131r.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel EVH Hisse Durumu ve Kritik Tarihler<\/h2>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla, Evolent Health (EVH) hisseleri <strong>9,64 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu fiyat, analistlerin potansiyel y\u00fckseli\u015f konusunda heyecanlanmas\u0131na neden oluyor. Ancak takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong>, bu hisseyi dramatik \u015fekilde hareket ettirebilecek bir sonraki kritik tarih.<\/p>\n<p>Evolent, 6 Kas\u0131m&#8217;da piyasa kapan\u0131\u015f\u0131ndan sonra 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, tarih bize \u00f6nemli fiyat hareketleri g\u00f6rebilece\u011fimizi g\u00f6steriyor. \u015eirketin 7 A\u011fustos 2025&#8217;teki son kazan\u00e7 raporu, beklenen 0,08 $&#8217;a kar\u015f\u0131l\u0131k -0,10 $ EPS a\u00e7\u0131\u011f\u0131 ile kar\u0131\u015f\u0131k sonu\u00e7lar g\u00f6sterdi, ancak piyasa tepkisi, daha geni\u015f stratejik ilerlemeler g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda \u015fa\u015f\u0131rt\u0131c\u0131 derecede pozitif oldu.<\/p>\n<p><strong>Tarihsel Kazan\u00e7 Etkisi Analizi:<\/strong><\/p>\n<ul>\n<li>7 A\u011fustos 2025: Kazan\u00e7 sonras\u0131 haftada hisse %7,97 de\u011fer kazand\u0131, a\u00e7\u0131\u011fa ra\u011fmen<\/li>\n<li>\u00d6nceki \u00e7eyrekler, kazan\u00e7 tarihleri civar\u0131nda ortalama %5-8 hareketler g\u00f6steriyor<\/li>\n<li>Sa\u011fl\u0131k teknolojisi hisseleri genellikle kazan\u00e7 sezonunda artan volatilite ya\u015far<\/li>\n<\/ul>\n<p>Bu desen, k\u0131sa vadeli sonu\u00e7lar\u0131n \u00f6nemli oldu\u011funu ancak yat\u0131r\u0131mc\u0131lar\u0131n giderek daha \u00e7ok Evolent&#8217;in uzun vadeli yapay zeka ve otomasyon stratejisine odakland\u0131\u011f\u0131n\u0131 g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu: M\u00fccadeleden F\u0131rsata<\/h2>\n<p>Evolent Health son alt\u0131 ayda ini\u015f \u00e7\u0131k\u0131\u015flar ya\u015fad\u0131, ancak son geli\u015fmeler bir d\u00f6n\u00fcm noktas\u0131n\u0131 i\u015faret ediyor:<\/p>\n<p><strong>Mart 2025:<\/strong> 11,25-12,27 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<br \/> <strong>May\u0131s 2025:<\/strong> Daha geni\u015f piyasa belirsizli\u011fi i\u00e7inde yakla\u015f\u0131k 10,50 $ seviyesine d\u00fc\u015ft\u00fc<br \/> <strong>Temmuz 2025:<\/strong> G\u00fc\u00e7l\u00fc destekle 9,50 $ civar\u0131nda dip olu\u015fumu<br \/> <strong>A\u011fustos 2025:<\/strong> Yukar\u0131 y\u00f6nl\u00fc momentumla mevcut 9,64 $ seviyesine toparland\u0131<\/p>\n<p>Hisse, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 7,06 $&#8217;dan \u00f6nemli bir toparlanma g\u00f6stererek <strong>%21&#8217;lik bir iyile\u015fme<\/strong> sergiledi. \u00d6zellikle ilgi \u00e7ekici olan, i\u015flem hacmi desenidir\u2014son i\u015flem seanslar\u0131nda artan kurumsal ilgi g\u00f6zlemleniyor, bu da ak\u0131ll\u0131 paran\u0131n bu seviyelerde birikti\u011fini g\u00f6steriyor.<\/p>\n<p>Teknik g\u00f6stergeler pozitif sinyaller vermeye ba\u015flad\u0131; hisse \u00f6nemli hareketli ortalamalar\u0131n \u00fczerinde i\u015flem g\u00f6r\u00fcyor ve genel sa\u011fl\u0131k sekt\u00f6r\u00fcyle kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda g\u00f6receli g\u00fcc\u00fcn\u00fc art\u0131r\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, bekleyebilecekleriniz \u015funlar:<\/p>\n<p><strong>2025 Y\u0131l Sonu Hedefi:<\/strong> 14-16 $ (mevcut seviyelerden %45-65 y\u00fckseli\u015f)<br \/> Analistler &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecesini koruyor ve ortalama fiyat hedefi 16,93 $ (<a href=\"https:\/\/stockanalysis.com\/stocks\/evh\/forecast\/\">Stock Analysis<\/a>). Son d\u00f6n\u00fc\u015ft\u00fcr\u00fclebilir tahvil ihrac\u0131 ve yapay zeka platformu geni\u015flemesi g\u00fc\u00e7l\u00fc kataliz\u00f6rler sa\u011fl\u0131yor.<\/p>\n<p><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc:<\/strong> 18-22 $<br \/> Auth Intelligence platformu ivme kazand\u0131k\u00e7a ve yeni ortakl\u0131klar olgunla\u015ft\u0131k\u00e7a, gelir b\u00fcy\u00fcmesi h\u0131zlanmal\u0131 ve otomasyon avantajlar\u0131yla marjlar geni\u015flemeli.<\/p>\n<p><strong>2028 Projeksiyonu:<\/strong> 28-35 $<br \/> 2028 y\u0131l\u0131na kadar, Evolent&#8217;in yapay zeka destekli \u00e7\u00f6z\u00fcmleri, 150 milyar dolarl\u0131k uzman bak\u0131m toplam adreslenebilir pazar\u0131nda \u00f6nemli pazar pay\u0131 yakalayabilir ve de\u011ferlemeyi \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rabilir.<\/p>\n<p><strong>2030 Vizyonu:<\/strong> 40-50+ $<br \/> Uzun vadeli analistler, Evolent&#8217;in 2030&#8217;da 40,52 $ seviyesine ula\u015fabilece\u011fini \u00f6ng\u00f6r\u00fcyor (<a href=\"https:\/\/stockscan.io\/stocks\/EVH\/forecast\/\">StockScan<\/a>), bu da sab\u0131rl\u0131 yat\u0131r\u0131mc\u0131lar i\u00e7in ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme anlam\u0131na geliyor.<\/p>\n<p><strong>Karar: G\u00dc\u00c7L\u00dc AL<\/strong> &#8211; Mevcut seviyelerde risk-getiri oran\u0131 uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in olduk\u00e7a elveri\u015fli g\u00f6r\u00fcn\u00fcyor.<\/p>\n<h2>\u26a0\ufe0f Riskleri Anlamak: Neler Yanl\u0131\u015f Gidebilir<\/h2>\n<p>Her yat\u0131r\u0131m risk ta\u015f\u0131r ve EVH de istisna de\u011fil. \u0130\u015fte deneyimli yat\u0131r\u0131mc\u0131lar\u0131n geceleri uykusunu ka\u00e7\u0131ranlar:<\/p>\n<ul>\n<li><strong>Reg\u00fclasyon Riski:<\/strong> Sa\u011fl\u0131k sekt\u00f6r\u00fc s\u0131k\u0131 d\u00fczenlemelere tabidir ve politika de\u011fi\u015fiklikleri Evolent&#8217;in i\u015f modelini etkileyebilir. \u015eirket, farkl\u0131 uyum gereksinimlerine sahip bir\u00e7ok eyalette faaliyet g\u00f6steriyor.<\/li>\n<li><strong>Uygulama Riski:<\/strong> Yapay zeka stratejisi umut verici g\u00f6r\u00fcnse de, ba\u015far\u0131l\u0131 uygulama garantili de\u011fil. Sa\u011fl\u0131k teknolojisi alan\u0131, iyi finanse edilmi\u015f rakiplerle dolu.<\/li>\n<li><strong>Mali Risk:<\/strong> 647,5 milyon $ uzun vadeli bor\u00e7 ve nakit rezervlerinin %50 azalarak 151 milyon $&#8217;a d\u00fc\u015fmesi (<a href=\"https:\/\/www.ainvest.com\/news\/evolent-health-q2-2025-earnings-strategic-turnaround-sustainable-recovery-temporary-bounce-2508\/\">AInvest<\/a>) nedeniyle \u015firketin bilan\u00e7osunu dikkatle y\u00f6netmesi gerekiyor.<\/li>\n<li><strong>Piyasa Riski:<\/strong> 1,13 milyar $ piyasa de\u011feri ile EVH, k\u00f6kl\u00fc sa\u011fl\u0131k devlerine k\u0131yasla daha y\u00fcksek volatiliteye sahip k\u00fc\u00e7\u00fck sermayeli bir hisse senedidir.<\/li>\n<\/ul>\n<h2>\ud83d\ude80 Pozitif Sinyaller: Bu 2025 Ticaretinizin En \u0130yisi Olabilir<\/h2>\n<p>Risklere ra\u011fmen, birka\u00e7 g\u00fc\u00e7l\u00fc kataliz\u00f6r EVH&#8217;nin ola\u011fan\u00fcst\u00fc getiri sa\u011flayabilece\u011fini g\u00f6steriyor:<\/p>\n<ul>\n<li><strong>Yapay Zeka Devrimi:<\/strong> Auth Intelligence platformunun idari maliyetleri %20-30 oran\u0131nda azaltmas\u0131 bekleniyor (<a href=\"https:\/\/www.ainvest.com\/news\/evolent-health-strategic-position-evolving-managed-care-landscape-2508\/\">AInvest<\/a>), bu da b\u00fcy\u00fck verimlilik art\u0131\u015flar\u0131 yaratacak.<\/li>\n<li><strong>B\u00fcy\u00fcyen \u0130\u015f Hatt\u0131:<\/strong> CEO Seth Blackley, &#8220;yeni i\u015f i\u00e7in h\u0131zla ivmelenen bir i\u015f hatt\u0131&#8221; oldu\u011funu ve 2026&#8217;da b\u00fcy\u00fcme oranlar\u0131n\u0131n tarihsel seviyelerin \u00fczerine \u00e7\u0131kmas\u0131n\u0131n beklendi\u011fini vurgulad\u0131.<\/li>\n<li><strong>Stratejik Finansman:<\/strong> Son 145 milyon $ tutar\u0131ndaki d\u00f6n\u00fc\u015ft\u00fcr\u00fclebilir tahvil ihrac\u0131 (<a href=\"https:\/\/www.prnewswire.com\/news-releases\/evolent-health-inc-announces-pricing-of-oversubscribed-and-upsized-145-0-million-of-convertible-senior-notes-due-2031-to-repurchase-existing-notes-and-class-a-common-stock-302533122.html\">PR Newswire<\/a>) a\u015f\u0131r\u0131 talep g\u00f6rd\u00fc ve g\u00fc\u00e7l\u00fc kurumsal g\u00fcveni g\u00f6sterdi.<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131:<\/strong> De\u011fer odakl\u0131 bak\u0131m standart haline geliyor ve Evolent bu 150 milyar dolarl\u0131k pazar de\u011fi\u015fiminden faydalanmak i\u00e7in m\u00fckemmel konumda.<\/li>\n<\/ul>\n<h2>\ud83d\udca1 Ak\u0131ll\u0131 Yat\u0131r\u0131mc\u0131 Stratejisi: Bug\u00fcn Ne Yapmal\u0131<\/h2>\n<p>EVH&#8217;ye yeni ba\u015flayanlar i\u00e7in eylem plan\u0131n\u0131z \u015f\u00f6yle:<\/p>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, sat\u0131n almalar\u0131n\u0131z\u0131 birka\u00e7 haftaya yayarak yap\u0131n<\/li>\n<li><strong>6 Kas\u0131m \u0130\u00e7in Uyar\u0131 Kurun<\/strong>: Kazan\u00e7lar ge\u00e7ici bir d\u00fc\u015f\u00fc\u015f yarat\u0131rsa sat\u0131n almaya haz\u0131r olun<\/li>\n<li><strong>Uzun Vadeli D\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 2-3 y\u0131ll\u0131k bir hikaye, h\u0131zl\u0131 bir i\u015flem de\u011fil<\/li>\n<\/ol>\n<p>Mizahi deneyimli tavsiye: &#8220;EVH ticareti, t\u0131bbi test sonu\u00e7lar\u0131n\u0131 beklemek gibidir\u2014beklemek ac\u0131 verici ama te\u015fhis portf\u00f6y\u00fcn\u00fcz i\u00e7in hayat de\u011fi\u015ftirebilir!&#8221;<\/p>\n<h2>\u2705 Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m S\u00fcre\u00e7<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve rekabet\u00e7i \u00fccretler sunan bir platform se\u00e7in<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Gerekli belgeleri sa\u011flay\u0131n\u2014bu genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon Yat\u0131r\u0131n<\/td>\n<td>Tercih etti\u011finiz y\u00f6ntemle para transferi yap\u0131n (banka transferi vb.)<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;EVH&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirket ad\u0131ndan ziyade sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>G\u00fcncel Fiyat\u0131 \u0130nceleyin<\/td>\n<td>9,64 $&#8217;\u0131n platformunuzun fiyat teklifiyle uyumlu oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in &#8220;limit emir&#8221; kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Hisse Adedini Belirleyin<\/td>\n<td>Risk y\u00f6netimi plan\u0131n\u0131za uygun ka\u00e7 hisse alaca\u011f\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>\u0130\u015flemi ger\u00e7ekle\u015ftirmeden \u00f6nce t\u00fcm detaylar\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Pozisyonunuzu Takip Edin<\/td>\n<td>Hedef seviyeleriniz i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u00c7\u0131k\u0131\u015f Stratejinizi Planlay\u0131n<\/td>\n<td>K\u00e2r almay\u0131 veya zarar\u0131 durdurmay\u0131 \u00f6nceden kararla\u015ft\u0131r\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83c\udf1f Pocket Option, EVH Yat\u0131r\u0131m\u0131n\u0131 Neden Kolayla\u015ft\u0131r\u0131yor<\/h2>\n<p>Evolent Health gibi umut vadeden hisselerde pozisyon olu\u015fturmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option, s\u00fcreci basitle\u015ftiren birka\u00e7 avantaj sunuyor:<\/p>\n<ul>\n<li><strong>Minimum Yat\u0131r\u0131m Sadece 5 $<\/strong> &#8211; \u00d6\u011frenmek i\u00e7in rahat bir miktarla ba\u015flayabilirsiniz<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong> &#8211; Genellikle sadece bir belge ile dakikalar i\u00e7inde tamamlan\u0131r<\/li>\n<li><strong>\u00c7e\u015fitli Fonlama Se\u00e7enekleri<\/strong> &#8211; Y\u00fczlerce para yat\u0131rma ve \u00e7ekme y\u00f6ntemi mevcut<\/li>\n<li><strong>Par\u00e7al\u0131 Hisseler<\/strong> &#8211; Daha k\u00fc\u00e7\u00fck miktarlarla bile pozisyonunuzu kademeli olarak olu\u015fturabilirsiniz<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, teknik karma\u015f\u0131kl\u0131klardan ziyade yat\u0131r\u0131m kararlar\u0131na odaklanmak isteyen yeni ba\u015flayanlar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udfe5 2025&#8217;te Evolent Health: Sa\u011fl\u0131k Hizmetlerinde D\u00f6n\u00fc\u015f\u00fcm<\/h2>\n<p>Evolent Health, kanser, kardiyovask\u00fcler hastal\u0131klar ve kas-iskelet sistemi bozukluklar\u0131 gibi karma\u015f\u0131k durumlar i\u00e7in de\u011fer odakl\u0131 bak\u0131m \u00e7\u00f6z\u00fcmlerinde \u00f6nc\u00fc konumdad\u0131r. \u015eirket, \u00fclke genelinde sa\u011fl\u0131k planlar\u0131 ve sa\u011flay\u0131c\u0131larla ortakl\u0131klar arac\u0131l\u0131\u011f\u0131yla yakla\u015f\u0131k 41,4 milyon \u00fcyeye hizmet vermektedir.<\/p>\n<p>Evolent&#8217;i 2025&#8217;te \u00f6zellikle heyecan verici k\u0131lan, yapay zeka destekli \u00e7\u00f6z\u00fcmlere y\u00f6nelik agresif ilerleyi\u015fidir. Auth Intelligence platformu, idari maliyetleri azalt\u0131rken hasta sonu\u00e7lar\u0131n\u0131 iyile\u015ftirmede bir at\u0131l\u0131m\u0131 temsil ediyor. 2025&#8217;in 2. \u00e7eyre\u011finde d\u00f6rt yeni ortakl\u0131k sa\u011flanm\u0131\u015f ve h\u0131zla geni\u015fleyen bir i\u015f hatt\u0131 ile \u015firket \u00f6nemli b\u00fcy\u00fcme i\u00e7in konumlanm\u0131\u015ft\u0131r.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Evolent&#8217;in yapay zeka platformu, insan y\u00f6neticilerin saatlerce s\u00fcren t\u0131bbi onay taleplerini sadece saniyeler i\u00e7inde, %95&#8217;in \u00fczerinde do\u011frulukla i\u015fleyebiliyor. Bu sadece kademeli bir iyile\u015fme de\u011fil; sa\u011fl\u0131k y\u00f6netiminin dijital \u00e7a\u011f i\u00e7in yeniden icad\u0131d\u0131r.<\/p>\n"},"faq":[{"question":"Evolent Health hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"EVH\" sembol\u00fc ile arama yap\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emir kullanarak hisse sat\u0131n al\u0131n."},{"question":"EVH hisseleri i\u00e7in riskler nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, strateji uygulama zorluklar\u0131, finansal bor\u00e7lar ve piyasa volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"EVH hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistler 14-16 $ aral\u0131\u011f\u0131nda bir fiyat hedefi belirlemi\u015f olup, bu mevcut seviyelerden %45-65 aras\u0131nda bir y\u00fckseli\u015f anlam\u0131na gelir."},{"question":"Pocket Option platformunun avantajlar\u0131 nelerdir?","answer":"Minimum 5 $ depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da fonlama se\u00e7ene\u011fi ve par\u00e7al\u0131 hisse al\u0131m\u0131 gibi kolayl\u0131klar sunar."},{"question":"EVH hisseleri i\u00e7in uzun vadeli yat\u0131r\u0131m stratejisi nedir?","answer":"Pozisyonu k\u00fc\u00e7\u00fck tutmak, dolar maliyet ortalamas\u0131 yapmak, \u00f6nemli kazan\u00e7 tarihleri i\u00e7in uyar\u0131 kurmak ve 2-3 y\u0131l gibi uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Evolent Health hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, fon yat\u0131r\u0131n, \"EVH\" sembol\u00fc ile arama yap\u0131n, g\u00fcncel fiyat\u0131 kontrol edin, limit emir kullanarak hisse sat\u0131n al\u0131n."},{"question":"EVH hisseleri i\u00e7in riskler nelerdir?","answer":"Reg\u00fclasyon de\u011fi\u015fiklikleri, strateji uygulama zorluklar\u0131, finansal bor\u00e7lar ve piyasa volatilitesi ba\u015fl\u0131ca risklerdir."},{"question":"EVH hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistler 14-16 $ aral\u0131\u011f\u0131nda bir fiyat hedefi belirlemi\u015f olup, bu mevcut seviyelerden %45-65 aras\u0131nda bir y\u00fckseli\u015f anlam\u0131na gelir."},{"question":"Pocket Option platformunun avantajlar\u0131 nelerdir?","answer":"Minimum 5 $ depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da fonlama se\u00e7ene\u011fi ve par\u00e7al\u0131 hisse al\u0131m\u0131 gibi kolayl\u0131klar sunar."},{"question":"EVH hisseleri i\u00e7in uzun vadeli yat\u0131r\u0131m stratejisi nedir?","answer":"Pozisyonu k\u00fc\u00e7\u00fck tutmak, dolar maliyet ortalamas\u0131 yapmak, \u00f6nemli kazan\u00e7 tarihleri i\u00e7in uyar\u0131 kurmak ve 2-3 y\u0131l gibi uzun vadeli d\u00fc\u015f\u00fcnmek \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T06:21:42+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T06:21:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\",\"name\":\"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"datePublished\":\"2025-09-01T06:21:42+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/","og_locale":"tr_TR","og_type":"article","og_title":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T06:21:42+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T06:21:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/","name":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","datePublished":"2025-09-01T06:21:42+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals9-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-evolent-health\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Evolent Health, Inc. (EVH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Evolent Health, Inc. (EVH) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":365455,"slug":"how-to-buy-evolent-health","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Evolent Health, Inc. (EVH) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Evolent Health, Inc. (EVH)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-evolent-health\/"},"pt_AA":{"locale":"pt_AA","id":365454,"slug":"how-to-buy-evolent-health","post_title":"Como comprar a\u00e7\u00f5es da Evolent Health, Inc. (EVH) - Investimento em a\u00e7\u00f5es da Evolent Health, Inc. (EVH)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-evolent-health\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/365452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=365452"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/365452\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334063"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=365452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=365452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=365452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}